Intra-Cellular Therapies ... (ITCI)
undefined
undefined%
At close: undefined
83.72
-0.08%
After-hours Jan 03, 2025, 04:00 PM EST

Intra-Cellular Therapies Inc. Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for ITCI stock have an median target of 93.5, with a low estimate of 74 and a high estimate of 113. The median target predicts an increase of 11.59% from the current stock price of 83.79.

Analyst Consensus: Buy
Target Low Average Median High
Price $74 $94.5 $93.5 $113
Change -11.68% 12.78% 11.59% 34.86%

AI Analyst Report

Needham has reaffirmed a Buy rating for Intra-Cell... Unlock content with Pro Subscription

Updated Oct 31, 2024

Rating Jun 24Jul 24Aug 24Sep 24Oct 24Nov 24
Strong Buy 310000
Buy 305341
Hold 102000
Sell 000000
Strong Sell 000000
Total 7 1 7 3 4 1

Financial Forecast this Year

Revenue This Year
914.02M
from -
Increased by ∞B%
Revenue Next Year
1.36B
from 914.02M
Increased by 48.9%
EPS This Year
0.65
from null
Increased by ∞B%
EPS Next Year
3.49
from 0.65
Increased by 436.9%